Targeting the metastasis suppressor NDRG1 for the treatment of pancreatic cancer.

靶向转移抑制因子 NDRG1 治疗胰腺癌。

• 批准号: nhmrc : 1037323
• 负责人: Dr Zaklina Kovacevic
• 金额: $ 21.81万
• 依托单位: Australian National University
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/targeting-metastasis-suppressor-pancreatic-cancer/111071
• 关键词: Targeting; metastasis; suppressor; NDRG1; treatment

We will investigate NDRG1, a novel molecular target that has been demonstrated to inhibit the progression of numerous cancers. We aim to better understand the underlying functions of NDRG1 in pancreatic cancer and how we can potentially target this gene with novel therapeutics being developed in our laboratory. We hope that this new approach will lead to more promising treatment options and a better outcome for those suffering from pancreatic cancer.

我们将研究NDRG1，这是一个新的分子靶点，已被证明可以抑制许多癌症的进展。我们的目标是更好地了解NDRG1在胰腺癌中的潜在功能，以及我们实验室正在开发的新疗法如何潜在地针对该基因。我们希望这一新方法将为胰腺癌患者带来更有希望的治疗选择和更好的结果。